DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $239,266,649 | -1.5% | 964,396 | -4.7% | 0.36% | +2.3% |
| Q2 2023 | $242,800,560 | -12.9% | 1,011,669 | -8.5% | 0.35% | -16.1% |
| Q1 2023 | $278,732,295 | -7.3% | 1,105,905 | -2.4% | 0.42% | -13.0% |
| Q4 2022 | $300,711,039 | +3.2% | 1,132,963 | +0.4% | 0.48% | -1.0% |
| Q3 2022 | $291,333,000 | +1.0% | 1,127,932 | -0.9% | 0.48% | +9.5% |
| Q2 2022 | $288,586,000 | -18.4% | 1,138,313 | -4.3% | 0.44% | -5.8% |
| Q1 2022 | $353,717,000 | -6.8% | 1,189,518 | +3.1% | 0.47% | -5.8% |
| Q4 2021 | $379,623,000 | +20.6% | 1,153,833 | +11.6% | 0.50% | +2.5% |
| Q3 2021 | $314,841,000 | +2.8% | 1,034,167 | -9.4% | 0.48% | +26.0% |
| Q2 2021 | $306,210,000 | +22.1% | 1,141,042 | +2.4% | 0.38% | +18.2% |
| Q1 2021 | $250,764,000 | -46.2% | 1,114,114 | -46.9% | 0.32% | -0.6% |
| Q4 2020 | $465,680,000 | +37.2% | 2,096,344 | +31.2% | 0.33% | -39.8% |
| Q3 2020 | $339,491,000 | +22.6% | 1,597,611 | +2.1% | 0.54% | +8.2% |
| Q2 2020 | $276,797,000 | +11.6% | 1,565,331 | -10.4% | 0.50% | -5.3% |
| Q1 2020 | $247,999,000 | -11.9% | 1,747,209 | -4.7% | 0.53% | +15.5% |
| Q4 2019 | $281,461,000 | -27.6% | 1,833,860 | -33.2% | 0.46% | -33.0% |
| Q3 2019 | $388,725,000 | +8.0% | 2,746,009 | +9.0% | 0.68% | +4.7% |
| Q2 2019 | $359,895,000 | +26.5% | 2,518,155 | +16.9% | 0.65% | +29.2% |
| Q1 2019 | $284,462,000 | +28.2% | 2,154,690 | +0.1% | 0.51% | +26.2% |
| Q4 2018 | $221,912,000 | -23.5% | 2,151,980 | -19.3% | 0.40% | -19.5% |
| Q3 2018 | $289,914,000 | +6.3% | 2,668,087 | -3.5% | 0.50% | +4.2% |
| Q2 2018 | $272,768,000 | +1.1% | 2,765,853 | +0.3% | 0.48% | +2.1% |
| Q1 2018 | $269,865,000 | +185.2% | 2,756,247 | +170.4% | 0.47% | +201.9% |
| Q4 2017 | $94,618,000 | +10.5% | 1,019,371 | +1.2% | 0.16% | +4.0% |
| Q3 2017 | $85,656,000 | -8.7% | 1,007,235 | -9.8% | 0.15% | -11.8% |
| Q2 2017 | $93,825,000 | -55.8% | 1,116,564 | -54.9% | 0.17% | -11.5% |
| Q1 2017 | $212,190,000 | +109.7% | 2,475,386 | +90.4% | 0.19% | -1.5% |
| Q4 2016 | $101,201,000 | -46.5% | 1,300,130 | -46.2% | 0.19% | -45.2% |
| Q3 2016 | $189,333,000 | -14.6% | 2,415,258 | +10.0% | 0.35% | -20.4% |
| Q2 2016 | $221,773,000 | +9.5% | 2,195,765 | +3.1% | 0.44% | +6.2% |
| Q1 2016 | $202,480,000 | -4.6% | 2,130,686 | -6.8% | 0.42% | -4.3% |
| Q4 2015 | $212,306,000 | +17.3% | 2,285,806 | +7.6% | 0.44% | +14.4% |
| Q3 2015 | $181,017,000 | +4.3% | 2,124,372 | +3.8% | 0.38% | +12.3% |
| Q2 2015 | $173,519,000 | -17.0% | 2,047,410 | -16.9% | 0.34% | -16.6% |
| Q1 2015 | $209,157,000 | -8.8% | 2,465,041 | -7.9% | 0.41% | -9.1% |
| Q4 2014 | $229,356,000 | -99.9% | 2,675,959 | +7.8% | 0.45% | +78.6% |
| Q3 2014 | $188,573,169,000 | +2.3% | 2,481,879 | +6.0% | 0.25% | +10.0% |
| Q2 2014 | $184,264,809,000 | -8.0% | 2,340,465 | -12.3% | 0.23% | +1.3% |
| Q1 2014 | $200,186,850,000 | +8.4% | 2,669,158 | +11.5% | 0.23% | -2.2% |
| Q4 2013 | $184,739,368,000 | -0.8% | 2,392,997 | -11.0% | 0.23% | -48.9% |
| Q3 2013 | $186,311,711,000 | +14.7% | 2,687,705 | +4.8% | 0.45% | +5.1% |
| Q2 2013 | $162,398,366,000 | – | 2,565,535 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |